IES Holdings has transformed into a structurally stronger business, driven by data center and infrastructure segment growth. IESC's record margins and backlog reflect a favorable business mix, but ...
In the golden hills of Puglia, a southern region of Italy known today for its olive trees, white cliffs and turquoise mediterranean coves, Lorenzo Avello has artificial intelligence on his mind.
Kalaris Therapeutics offers a differentiated approach to neovascular AMD with its lead candidate TH103, leveraging unique molecular engineering for improved efficacy and durability. KLRS's Phase 1a ...
New York City is seeing some of the highest levels in the country. Flu activity is increasing across the country, according to the latest data from the Centers for Disease Control and Prevention. New ...
Automatic control systems, embedded systems, cyber-physical systems, real-time systems, reactive systems: All of these refer to computer systems that interact continuously with their environment, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A prominent Arizona real estate ...
Environmental Protection Agency Administrator Lee Zeldin testifies before the House Committee on Energy and Commerce Subcommittee on Environment in the Rayburn House Office Building on May 20, 2025 in ...
University of the Sunshine Coast provides funding as a member of The Conversation AU. Two centuries ago, US President James Monroe declared the Western Hemisphere off-limits to European powers in what ...
A company that most people have never heard of is among the year’s best-performing technology firms—and a symbol of the complex, interconnected, and potentially catastrophic ways in which AI companies ...
When it comes to football, I don’t really want to think about math. (When it comes to math, I don’t really want to think about math, either.) Analytics has its place. The problem is it’s now ...
Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...